Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Delarbre

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
La Revue Du Praticien|November 18, 2021
[Restatment. Mollaret's meningitis]Anne Perisse, David Delarbre, Anthony Faivre
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|November 2, 2023
Disseminated tuberculosis after anti-TNF alpha treatment: Do not blindly trust the IGRA testDavid Delarbre, Camille Junca-Laplace, Marie-Pierre Otto, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
Rationale Efficacy and Safety Evidence of Lenvatinib and Pembrolizumab Association in Anaplastic Thyroid CarcinomaLaurys Boudin, Jean-Baptiste Morvan, Juliette Thariat, et al.
Diagnostic Microbiology and Infectious Disease|July 17, 2024
Bacterial DNA enrichment for low-inoculum fracture-related infection diagnostic using high-throughput sequencingDavid Delarbre, Philippe Lavrard, Antoine Elias, et al.
BMC Infectious Diseases|November 4, 2025
Post-spinal surgery infections: a two-year follow-up study on risks, resistance, and recoveryAymery Stheme De Jubecourt, Piseth Seng, David Delarbre, et al.
Current Oncology (Toronto, Ont.)|December 22, 2022
Internal Jugular Vein Tumor Thrombus: A Tricky Question for the Thyroid SurgeonJean-Baptiste Morvan, Laurys Boudin, Denis Metivier, et al.
Autoimmunity Reviews|December 16, 2020
Combined Anakinra and Ruxolitinib treatment to rescue extremely ill COVID-19 patients: A pilot studyGilles Kaplanski, Denis Bontemps, Pierre Esnault, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 11, 2021
Neutralizing antibody response to SARS-CoV-2 persists 9 months post symptom onset in mild and asymptomatic patientsOlivier Bylicki, David Delarbre, Aurélie Mayet, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2020
Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19Raphaël Cauchois, Marie Koubi, David Delarbre, et al.
The Lancet. Microbe|October 12, 2024
Reappraising Cladophialophora bantiana phaeohyphomycosis in France: retrospective nation-based studyOlivier Lortholary, Dea Garcia-Hermoso, Aude Sturny-Leclère, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
La Revue Du Praticien|November 18, 2021
[Restatment. Mollaret's meningitis]Anne Perisse, David Delarbre, Anthony Faivre
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|November 2, 2023
Disseminated tuberculosis after anti-TNF alpha treatment: Do not blindly trust the IGRA testDavid Delarbre, Camille Junca-Laplace, Marie-Pierre Otto, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
Rationale Efficacy and Safety Evidence of Lenvatinib and Pembrolizumab Association in Anaplastic Thyroid CarcinomaLaurys Boudin, Jean-Baptiste Morvan, Juliette Thariat, et al.
Diagnostic Microbiology and Infectious Disease|July 17, 2024
Bacterial DNA enrichment for low-inoculum fracture-related infection diagnostic using high-throughput sequencingDavid Delarbre, Philippe Lavrard, Antoine Elias, et al.
BMC Infectious Diseases|November 4, 2025
Post-spinal surgery infections: a two-year follow-up study on risks, resistance, and recoveryAymery Stheme De Jubecourt, Piseth Seng, David Delarbre, et al.
Current Oncology (Toronto, Ont.)|December 22, 2022
Internal Jugular Vein Tumor Thrombus: A Tricky Question for the Thyroid SurgeonJean-Baptiste Morvan, Laurys Boudin, Denis Metivier, et al.
Autoimmunity Reviews|December 16, 2020
Combined Anakinra and Ruxolitinib treatment to rescue extremely ill COVID-19 patients: A pilot studyGilles Kaplanski, Denis Bontemps, Pierre Esnault, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 11, 2021
Neutralizing antibody response to SARS-CoV-2 persists 9 months post symptom onset in mild and asymptomatic patientsOlivier Bylicki, David Delarbre, Aurélie Mayet, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2020
Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19Raphaël Cauchois, Marie Koubi, David Delarbre, et al.
The Lancet. Microbe|October 12, 2024
Reappraising Cladophialophora bantiana phaeohyphomycosis in France: retrospective nation-based studyOlivier Lortholary, Dea Garcia-Hermoso, Aude Sturny-Leclère, et al.
Pageof 1